The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
Stromal cell diversity associated with immune evasion in human triple‐negative breast cancer
Open accessAbstract
The tumour stroma regulates nearly all stages of carcinogenesis. Stromal heterogeneity in human triple‐negative breast cancers (TNBCs) remains poorly understood, limiting the development of stromal‐targeted therapies. Single‐cell RNA sequencing of five TNBCs revealed two cancer‐associated fibroblast (CAF) and two perivascular‐like (PVL) subpopulations. CAFs clustered into two states: the first with features of myofibroblasts and the second characterised by high expression of growth factors and immunomodulatory molecules. PVL cells clustered into two states consistent with a differentiated and immature phenotype. We showed that these stromal states have distinct morphologies, spatial relationships and functional properties in regulating the extracellular matrix. Using cell signalling predictions, we provide evidence that stromal‐immune crosstalk acts via a diverse array of immunoregulatory molecules. Importantly, the investigation of gene signatures from inflammatory‐CAFs and differentiated‐PVL cells in independent TNBC patient cohorts revealed strong associations with cytotoxic T‐cell dysfunction and exclusion, respectively. Such insights present promising candidates to further investigate for new therapeutic strategies in the treatment of TNBCs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
Yu, G., Wang, L.-G., Han, Y., & He, Q.-Y. (2012) · OMICS: A Journal of Integrative Biology · doi:10.1089/omi.2011.0118 · Cited by 36,259
Integrating single-cell transcriptomic data across different conditions, technologies, and species
Butler, A., Hoffman, P., Smibert, P., Papalexi, E., & Satija, R. (2018) · Nature Biotechnology · doi:10.1038/nbt.4096 · Cited by 13,174 · cited 1×
“Individual Seurat objects were then integrated using the canonical correlation analysis (CCA) function RunMultiCCA according the developer guidelines (Butler et al, 2018).”
MethodComprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129
Spatial reconstruction of single-cell gene expression data
Satija, R., Farrell, J. A., Gennert, D., Schier, A. F., & Regev, A. (2015) · Nature Biotechnology · doi:10.1038/nbt.3192 · Cited by 7,055 · cited 11×
“CAFs, PVL cells and T cells were independently re-clustered using the Seurat v3 method.”
MethodInfluentialScenic: single-cell regulatory network inference and clustering.
Aibar, S., González-Blas, C. B., Moerman, T., Huynh-Thu, V. A., Imrichova, H., Hulselmans, G., Rambow, F., Marine, J.-C., Geurts, P., Aerts, J., et al. (2017) · Nature Methods · doi:10.1038/nmeth.4463 · Cited by 6,520
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
METABRIC Group, Curtis, C., Shah, S. P., Chin, S.-F., Turashvili, G., Rueda, O. M., Dunning, M. J., Speed, D., Lynch, A. G., Samarajiwa, S., et al. (2012) · Nature · doi:10.1038/nature10983 · Cited by 6,097
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
Jiang, P., Gu, S., Pan, D., Fu, J., Sahu, A., Hu, X., Li, Z., Traugh, N., Bu, X., Li, B., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0136-1 · Cited by 5,179
Self-citationSingle-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma
Patel, A. P., Tirosh, I., Trombetta, J. J., Shalek, A. K., Gillespie, S. M., Wakimoto, H., Cahill, D. P., Nahed, B. V., Curry, W. T., Martuza, R. L., et al. (2014) · Science · doi:10.1126/science.1254257 · Cited by 5,063
xCell: digitally portraying the tissue cellular heterogeneity landscape
Aran, D., Hu, Z., & Butte, A. J. (2017) · Genome Biology · doi:10.1186/s13059-017-1349-1 · Cited by 4,397
The biology and function of fibroblasts in cancer
Kalluri, R. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.73 · Cited by 4,366
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
Levental, K. R., Yu, H., Kass, L., Lakins, J. N., Egeblad, M., Erler, J. T., Fong, S. F. T., Csiszar, K., Giaccia, A., Weninger, W., et al. (2009) · Cell · doi:10.1016/j.cell.2009.10.027 · Cited by 4,101
A perivascular origin for mesenchymal stem cells in multiple human organs
Crisan, M., Yap, S., Casteilla, L., Chen, C.-W., Corselli, M., Park, T. S., Andriolo, G., Sun, B., Zheng, B., Zhang, L., et al. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.07.003 · Cited by 3,991 · cited 2×
“To investigate this, we generated cell-derived matrices (CDMs) to compare the ability of each human stromal subset to lay down collagen, as previously described (Cukierman et al, 2001).”
MethodFinak, G., McDavid, A., Yajima, M., Deng, J., Gersuk, V., Shalek, A. K., Slichter, C. K., Miller, H. W., McElrath, M. J., Prlic, M., et al. (2015) · Genome Biology · doi:10.1186/s13059-015-0844-5 · Cited by 3,159
Salgado, R., Denkert, C., Demaria, S., Sirtaine, N., Klauschen, F., Pruneri, G., Wienert, S., Van den Eynden, G., Baehner, F. L., Penault-Llorca, F., et al. (2015) · Annals of Oncology · doi:10.1093/annonc/mdu450 · Cited by 3,113
Taking Cell-Matrix Adhesions to the Third Dimension
Cukierman, E., Pankov, R., Stevens, D. R., & Yamada, K. M. (2001) · Science · doi:10.1126/science.1064829 · Cited by 3,027
Özdemir, B. C., Pentcheva-Hoang, T., Carstens, J. L., Zheng, X., Wu, C.-C., Simpson, T. R., Laklai, H., Sugimoto, H., Kahlert, C., Novitskiy, S. V., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.04.005 · Cited by 2,681
Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer
Öhlund, D., Handly-Santana, A., Biffi, G., Elyada, E., Almeida, A. S., Ponz-Sarvise, M., Corbo, V., Oni, T. E., Hearn, S. A., Lee, E. J., et al. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20162024 · Cited by 2,590
Puram, S. V., Tirosh, I., Parikh, A. S., Patel, A. P., Yizhak, K., Gillespie, S., Rodman, C., Luo, C. L., Mroz, E. A., Emerick, K. S., et al. (2017) · Cell · doi:10.1016/j.cell.2017.10.044 · Cited by 2,557
Elyada, E., Bolisetty, M., Laise, P., Flynn, W. F., Courtois, E. T., Burkhart, R. A., Teinor, J. A., Belleau, P., Biffi, G., Lucito, M. S., et al. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0094 · Cited by 2,241
Breast Density and Parenchymal Patterns as Markers of Breast Cancer Risk: A Meta-analysis
McCormack, V. A., & dos Santos Silva, I. (2006) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0034 · Cited by 2,143
Blackburn, S. D., Shin, H., Haining, W. N., Zou, T., Workman, C. J., Polley, A., Betts, M. R., Freeman, G. J., Vignali, D. A. A., & Wherry, E. J. (2009) · Nature Immunology · doi:10.1038/ni.1679 · Cited by 2,062
Single-cell mRNA quantification and differential analysis with Census
Qiu, X., Hill, A., Packer, J., Lin, D., Ma, Y.-A., & Trapnell, C. (2017) · Nature Methods · doi:10.1038/nmeth.4150 · Cited by 1,918
Recovering Gene Interactions from Single-Cell Data Using Data Diffusion
van Dijk, D., Sharma, R., Nainys, J., Yim, K., Kathail, P., Carr, A. J., Burdziak, C., Moon, K. R., Chaffer, C. L., Pattabiraman, D., et al. (2018) · Cell · doi:10.1016/j.cell.2018.05.061 · Cited by 1,829
Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer
Costa, A., Kieffer, Y., Scholer-Dahirel, A., Pelon, F., Bourachot, B., Cardon, M., Sirven, P., Magagna, I., Fuhrmann, L., Bernard, C., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.01.011 · Cited by 1,705 · cited 1×
“MCAM (also known as CD146) has shown to be a robust marker to differentiate perivascular cells from fibroblasts in human tissues (Li et al, 2003; Middleton et al, 2005; Covas et al, 2008; Crisan et al, 2008).”
BackgroundPhenotype molding of stromal cells in the lung tumor microenvironment
Lambrechts, D., Wauters, E., Boeckx, B., Aibar, S., Nittner, D., Burton, O., Bassez, A., Decaluwé, H., Pircher, A., Van den Eynde, K., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0096-5 · Cited by 1,648
Loi, S., Sirtaine, N., Piette, F., Salgado, R., Viale, G., Van Eenoo, F., Rouas, G., Francis, P., Crown, J. P. A., Hitre, E., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2011.41.0902 · Cited by 1,632
Biffi, G., Oni, T. E., Spielman, B., Hao, Y., Elyada, E., Park, Y., Preall, J., & Tuveson, D. A. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-0710 · Cited by 1,360
Aligned Collagen Is a Prognostic Signature for Survival in Human Breast Carcinoma
Conklin, M. W., Eickhoff, J. C., Riching, K. M., Pehlke, C. A., Eliceiri, K. W., Provenzano, P. P., Friedl, A., & Keely, P. J. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2010.11.076 · Cited by 1,285
Su, S., Chen, J., Yao, H., Liu, J., Yu, S., Lao, L., Wang, M., Luo, M., Xing, Y., Chen, F., et al. (2018) · Cell · doi:10.1016/j.cell.2018.01.009 · Cited by 1,230
T-cell exhaustion in the tumor microenvironment
Jiang, Y., Li, Y., & Zhu, B. (2015) · Cell Death & Disease · doi:10.1038/cddis.2015.162 · Cited by 1,157
Jamboree, P. I. T. 1. H. C. A., Lun, A. T. L., Riesenfeld, S., Andrews, T., Dao, T. P., Gomes, T., & Marioni, J. C. (2019) · Genome Biology · doi:10.1186/s13059-019-1662-y · Cited by 1,097
Rezakhaniha, R., Agianniotis, A., Schrauwen, J. T. C., Griffa, A., Sage, D., Bouten, C. V. C., van de Vosse, F. N., Unser, M., & Stergiopulos, N. (2012) · Biomechanics and Modeling in Mechanobiology · doi:10.1007/s10237-011-0325-z · Cited by 1,096
The Role of the IGF System in Cancer Growth and Metastasis: Overview and Recent Insights
Samani, A. A., Yakar, S., LeRoith, D., & Brodt, P. (2007) · Endocrine Reviews · doi:10.1210/er.2006-0001 · Cited by 1,005
A draft network of ligand–receptor-mediated multicellular signalling in human
Ramilowski, J. A., Goldberg, T., Harshbarger, J., Kloppmann, E., Lizio, M., Satagopam, V. P., Itoh, M., Kawaji, H., Carninci, P., Rost, B., et al. (2015) · Nature Communications · doi:10.1038/ncomms8866 · Cited by 887
Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming
Tian, L., Goldstein, A., Wang, H., Ching Lo, H., Sun Kim, I., Welte, T., Sheng, K., Dobrolecki, L. E., Zhang, X., Putluri, N., et al. (2017) · Nature · doi:10.1038/nature21724 · Cited by 841 · cited 1×
“In addition, signalling between CD4+ T cells and pericytes have also been reported to play a reciprocal role in tumour vessel normalisation (Tian et al, 2017).”
BackgroundBartoschek, M., Oskolkov, N., Bocci, M., Lövrot, J., Larsson, C., Sommarin, M., Madsen, C. D., Lindgren, D., Pekar, G., Karlsson, G., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07582-3 · Cited by 826
Modulation of the antitumor immune response by complement
Markiewski, M. M., DeAngelis, R. A., Benencia, F., Ricklin-Lichtsteiner, S. K., Koutoulaki, A., Gerard, C., Coukos, G., & Lambris, J. D. (2008) · Nature Immunology · doi:10.1038/ni.1655 · Cited by 778
Fagiani, E., & Christofori, G. (2013) · Cancer Letters · doi:10.1016/j.canlet.2012.08.018 · Cited by 676
Chang, A. L., Miska, J., Wainwright, D. A., Dey, M., Rivetta, C. V., Yu, D., Kanojia, D., Pituch, K. C., Qiao, J., Pytel, P., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0144 · Cited by 640
GRNBoost2 and Arboreto: efficient and scalable inference of gene regulatory networks
Moerman, T., Aibar Santos, S., Bravo González-Blas, C., Simm, J., Moreau, Y., Aerts, J., & Aerts, S. (2019) · Bioinformatics · doi:10.1093/bioinformatics/bty916 · Cited by 621
Covas, D. T., Panepucci, R. A., Fontes, A. M., Silva, W. A., Orellana, M. D., Freitas, M. C. C., Neder, L., Santos, A. R. D., Peres, L. C., Jamur, M. C., et al. (2008) · Experimental Hematology · doi:10.1016/j.exphem.2007.12.015 · Cited by 610 · cited 2×
“MEF2C is a well-defined regulator for establishing vSMCs during development, highlighting a likely vSMC origin of the described PVL cells (Creemers et al, 2006; Gordon et al, 2009).”
BackgroundVascular normalization in Rgs5-deficient tumours promotes immune destruction
Hamzah, J., Jugold, M., Kiessling, F., Rigby, P., Manzur, M., Marti, H. H., Rabie, T., Kaden, S., Gröne, H.-J., Hämmerling, G. J., et al. (2008) · Nature · doi:10.1038/nature06868 · Cited by 564
Song, S., Ewald, A. J., Stallcup, W., Werb, Z., & Bergers, G. (2005) · Nature Cell Biology · doi:10.1038/ncb1288 · Cited by 548
Induction of Lymphoidlike Stroma and Immune Escape by Tumors That Express the Chemokine CCL21
Shields, J. D., Kourtis, I. C., Tomei, A. A., Roberts, J. M., & Swartz, M. A. (2010) · Science · doi:10.1126/science.1185837 · Cited by 506
Rønnov-Jessen, L., Petersen, O. W., Koteliansky, V. E., & Bissell, M. J. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117736 · Cited by 444
Cazet, A. S., Hui, M. N., Elsworth, B. L., Wu, S. Z., Roden, D., Chan, C.-L., Skhinas, J. N., Collot, R., Yang, J., Harvey, K., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05220-6 · Cited by 437
Self-citationPericyte–fibroblast transition promotes tumor growth and metastasis
Hosaka, K., Yang, Y., Seki, T., Fischer, C., Dubey, O., Fredlund, E., Hartman, J., Religa, P., Morikawa, H., Ishii, Y., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1608384113 · Cited by 415
Sautès-Fridman, C., Lawand, M., Giraldo, N. A., Kaplon, H., Germain, C., Fridman, W. H., & Dieu-Nosjean, M.-C. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00407 · Cited by 379
Fibroblast-specific protein 1 identifies an inflammatory subpopulation of macrophages in the liver
Österreicher, C. H., Penz-Österreicher, M., Grivennikov, S. I., Guma, M., Koltsova, E. K., Datz, C., Sasik, R., Hardiman, G., Karin, M., & Brenner, D. A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1017547108 · Cited by 337
Li, T., Sun, L., Miller, N., Nicklee, T., Woo, J., Hulse-Smith, L., Tsao, M.-S., Khokha, R., Martin, L., & Boyd, N. (2005) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0490 · Cited by 329
Jézéquel, P., Loussouarn, D., Guérin-Charbonnel, C., Campion, L., Vanier, A., Gouraud, W., Lasla, H., Guette, C., Valo, I., Verrièle, V., et al. (2015) · Breast Cancer Research · doi:10.1186/s13058-015-0550-y · Cited by 321
Lee, H.-O., Mullins, S. R., Franco-Barraza, J., Valianou, M., Cukierman, E., & Cheng, J. D. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-245 · Cited by 304
miR200-regulated CXCL12β promotes fibroblast heterogeneity and immunosuppression in ovarian cancers
Givel, A.-M., Kieffer, Y., Scholer-Dahirel, A., Sirven, P., Cardon, M., Pelon, F., Magagna, I., Gentric, G., Costa, A., Bonneau, C., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03348-z · Cited by 295 · cited 5×
“In addition, myofibroblast-like CAFs have been shown to contribute to an immunosuppressive microenvironment by attracting T-regulatory cells in breast and ovarian cancer (Costa et al, 2018; Givel et al, 2018).”
BackgroundInfluentialA gene expression signature identifies two prognostic subgroups of basal breast cancer
Sabatier, R., Finetti, P., Cervera, N., Lambaudie, E., Esterni, B., Mamessier, E., Tallet, A., Chabannon, C., Extra, J.-M., Jacquemier, J., et al. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0897-9 · Cited by 290
Hyun, K.-A., Koo, G.-B., Han, H., Sohn, J., Choi, W., Kim, S.-I., Jung, H.-I., & Kim, Y.-S. (2016) · Oncotarget · doi:10.18632/oncotarget.8250 · Cited by 274
The CRUK IMAXT Grand Challenge Team, O’Flanagan, C. H., Campbell, K. R., Zhang, A. W., Kabeer, F., Lim, J. L. P., Biele, J., Eirew, P., Lai, D., McPherson, A., et al. (2019) · Genome Biology · doi:10.1186/s13059-019-1830-0 · Cited by 269
Vennin, C., Chin, V. T., Warren, S. C., Lucas, M. C., Herrmann, D., Magenau, A., Melenec, P., Walters, S. N., del Monte-Nieto, G., Conway, J. R. W., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aai8504 · Cited by 267
Self-citationVascular smooth muscle cell motility: From migration to invasion.
Louis, S. F., & Zahradka, P. C. (2010) · PubMed · Cited by 256
Özdemir, B. C., Pentcheva-Hoang, T., Carstens, J. L., Zheng, X., Wu, C.-C., Simpson, T. R., Laklai, H., Sugimoto, H., Kahlert, C., Novitskiy, S. V., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.11.002 · Cited by 245
Mammary stem cells have myoepithelial cell properties
Prater, M. D., Petit, V., Alasdair Russell, I., Giraddi, R. R., Shehata, M., Menon, S., Schulte, R., Kalajzic, I., Rath, N., Olson, M. F., et al. (2014) · Nature Cell Biology · doi:10.1038/ncb3025 · Cited by 240
Fibroblast Subtypes Regulate Responsiveness of Luminal Breast Cancer to Estrogen
Brechbuhl, H. M., Finlay-Schultz, J., Yamamoto, T. M., Gillen, A. E., Cittelly, D. M., Tan, A.-C., Sams, S. B., Pillai, M. M., Elias, A. D., Robinson, W. A., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2851 · Cited by 228
Yamashita, M., Ogawa, T., Zhang, X., Hanamura, N., Kashikura, Y., Takamura, M., Yoneda, M., & Shiraishi, T. (2012) · Breast Cancer · doi:10.1007/s12282-010-0234-5 · Cited by 213
DeFilippis, R. A., Chang, H., Dumont, N., Rabban, J. T., Chen, Y.-Y., Fontenay, G. V., Berman, H. K., Gauthier, M. L., Zhao, J., Hu, D., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0107 · Cited by 212 · cited 1×
“Although it is yet to be studied in the context of perivascular cells, studies have reported that the imPVL marker CD36 is enriched in normal tissue regions and is associated with good survival outcome in breast cancer (DeFilippis et al, 2012).”
BackgroundKawase, A., Ishii, G., Nagai, K., Ito, T., Nagano, T., Murata, Y., Hishida, T., Nishimura, M., Yoshida, J., Suzuki, K., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.23611 · Cited by 208
Mayorca-Guiliani, A. E., Madsen, C. D., Cox, T. R., Horton, E. R., Venning, F. A., & Erler, J. T. (2017) · Nature Medicine · doi:10.1038/nm.4352 · Cited by 177
Self-citationTCF/LEF Transcription Factors: An Update from the Internet Resources
Hrckulak, D., Kolar, M., Strnad, H., & Korinek, V. (2016) · Cancers · doi:10.3390/cancers8070070 · Cited by 170
Huo, C. W., Chew, G., Hill, P., Huang, D., Ingman, W., Hodson, L., Brown, K. A., Magenau, A., Allam, A. H., McGhee, E., et al. (2015) · Breast Cancer Research · doi:10.1186/s13058-015-0592-1 · Cited by 168
Self-citationKisselbach, L., Merges, M., Bossie, A., & Boyd, A. L. (2009) · Cytotechnology · doi:10.1007/s10616-009-9190-3 · Cited by 150
Creemers, E. E., Sutherland, L. B., McAnally, J., Richardson, J. A., & Olson, E. N. (2006) · Development · doi:10.1242/dev.02610 · Cited by 149
Neri, S., Ishii, G., Hashimoto, H., Kuwata, T., Nagai, K., Date, H., & Ochiai, A. (2015) · International Journal of Cancer · doi:10.1002/ijc.29464 · Cited by 148
Sinn, M., Denkert, C., Striefler, J. K., Pelzer, U., Stieler, J., Bahra, M., Lohneis, P., Dörken, B., Oettle, H., Riess, H. B., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.495 · Cited by 141
Middleton, J., Americh, L., Gayon, R., Julien, D., Mansat, M., Mansat, P., Anract, P., Cantagrel, A. G., Cattan, P., Reimund, J., et al. (2005) · The Journal of Pathology · doi:10.1002/path.1788 · Cited by 119
Alarmo, E., Kuukasjärvi, T., Karhu, R., & Kallioniemi, A. H. (2006) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9362-1 · Cited by 118
Wang, F., Sun, W., Zhang, J., & Fan, Y. (2019) · Oncology Letters · doi:10.3892/ol.2019.9973 · Cited by 115
Enduring epigenetic landmarks define the cancer microenvironmentPreprint
Pidsley, R., Lawrence, M. G., Zotenko, E., Niranjan, B., Statham, A. L., Song, J. Z., Chabanon, R. M., Qu, W., Wang, H., Richards, M. G., et al. (2018) · Genome Research · doi:10.1101/gr.229070.117 · Cited by 111
Nguyen, E. V., Pereira, B. A., Lawrence, M. G., Ma, X., Rebello, R. J., Chan, H., Niranjan, B., Wu, Y., Ellem, S., Guan, X., et al. (2019) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra119.001496 · Cited by 107
Self-citationLi, Q., Yu, Y. H., Bischoff, J. E., Mulliken, J. B., & Olsen, B. R. (2003) · The Journal of Pathology · doi:10.1002/path.1443 · Cited by 102
Timpson, P., McGhee, E. J., Erami, Z., Nobis, M., Quinn, J. A., Edward, M., & Anderson, K. I. (2011) · Journal of Visualized Experiments · doi:10.3791/3089 · Cited by 101
Self-citationKLF2 Transcription Factor Modulates Blood Vessel Maturation through Smooth Muscle Cell Migration
Wu, J., Bohanan, C. S., Neumann, J. C., & Lingrel, J. B. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m707882200 · Cited by 100
Banerjee, S., Sengupta, K., Dhar, K., Mehta, S., D'Amore, P. A., Dhar, G., & Banerjee, S. K. (2006) · Molecular Carcinogenesis · doi:10.1002/mc.20248 · Cited by 94
Intratumoral LIGHT Restores Pericyte Contractile Properties and Vessel Integrity
Johansson, A., Li, Z., Lakhiani, D. D., He, B., Wang, X., Hamzah, J., & Ganß, R. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.12.004 · Cited by 91
Gr‐1+CD11b+ cells are responsible for tumor promoting effect of TGF‐β in breast cancer progression
Li, Z., Pang, Y., Gara, S. K., Achyut, B. R., Heger, C. D., Goldsmith, P. K., Lonning, S. M., & Yang, H. H. (2012) · International Journal of Cancer · doi:10.1002/ijc.27572 · Cited by 75
Palmieri, C., Roberts-Clark, D., Assadi-Sabet, A., Coope, R. C., O'Hare, M. J., Sunters, A., Hanby, A. M., Slade, M. J., Gomm, J., Lam, E. W. ‐., et al. (2003) · Journal of Endocrinology · doi:10.1677/joe.0.1770065 · Cited by 75
A ZEB1/p53 signaling axis in stromal fibroblasts promotes mammary epithelial tumours
Fu, R., Han, C., Ni, T., Di, L., Liu, L., Lv, W., Bi, Y.-R., Jiang, N., He, Y., Li, H., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11278-7 · Cited by 75
Paracrine Overexpression of Insulin-Like Growth Factor-1 Enhances Mammary Tumorigenesis in Vivo
de Ostrovich, K. K., Lambertz, I. U., Colby, J. K., Tian, J., Rundhaug, J. E., Johnston, D. A., Conti, C. J., DiGiovanni, J., & Fuchs‐Young, R. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.071005 · Cited by 74
Gordon, J. W., Pagiatakis, C., Salma, J., Du, ., Andreucci, J. J., Zhao, J., Hou, G., Perry, R. L., Dan, Q., Courtman, D. W., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.000539 · Cited by 66
FOXP1 enhances fibrosis via activating Wnt/β-catenin signaling pathway in endometriosis.
Shao, X. H., & Wei, X. L. (2018) · Europe PMC (PubMed Central) · Cited by 43
Conway, J. R. W., Vennin, C., Cazet, A., Herrmann, D., Murphy, K. J., Warren, S. C., Wullkopf, L., Boulghourjian, A., Zaratzian, A., Silva, A. M. D., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-17177-5 · Cited by 34
Self-citationDysregulation of nuclear receptor COUP-TFII impairs skeletal muscle development
Lee, H.-J., Kao, C., Lin, S., Xu, M., Xie, X., Tsai, S. Y., & Tsai, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-03475-5 · Cited by 31
Early Growth Response Genes Signaling Supports Strong Paracrine Capability of Mesenchymal Stem Cells
Tamama, K., & Barbeau, D. J. (2012) · Stem Cells International · doi:10.1155/2012/428403 · Cited by 27
Cited by
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
de Visser, K. E., & Joyce, J. A. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.02.016 · Cited by 4,059
A single-cell and spatially resolved atlas of human breast cancers
Wu, S. Z., Al-Eryani, G., Roden, D. L., Junankar, S., Harvey, K., Andersson, A., Thennavan, A., Wang, C., Torpy, J. R., Bartonicek, N., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00911-1 · Cited by 1,775
Self-citationClinical and therapeutic relevance of cancer-associated fibroblasts
Chen, Y., McAndrews, K. M., & Kalluri, R. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00546-5 · Cited by 1,230
Tertiary lymphoid structures in cancer
Schumacher, T. N., & Thommen, D. S. (2022) · Science · doi:10.1126/science.abf9419 · Cited by 1,142
Cancer-associated fibroblasts in the single-cell era
Lavie, D., Ben-Shmuel, A., Erez, N., & Scherz-Shouval, R. (2022) · Nature Cancer · doi:10.1038/s43018-022-00411-z · Cited by 616
Metadata
- Authors
- Wu, S. Z., Roden, D. L., Wang, C., Holliday, H., Harvey, K., Cazet, A. S., Murphy, K. J., Pereira, B., Al‐Eryani, G., Bartonicek, N., Hou, R., Torpy, J. R., Junankar, S., Chan, C., Lam, C. E., Hui, M. N., Gluch, L., Beith, J., Parker, A., Robbins, E., Segara, D., Mak, C., Cooper, C., Warrier, S., Forrest, A., Powell, J., O'Toole, S., Cox, T. R., Timpson, P., Lim, E., Liu, X. S., & Swarbrick, A.
- Venue
- The EMBO Journal
- Published
- 2020-08-13
- Volume
- 39
- Issue
- 19
- Pages
- e104063-e104063
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- OpenAlex
- W3048888372
- Cited by
- 436
- References
- 90
- FWCI
- 15.56
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.